tradingkey.logo
tradingkey.logo
Search

China SXT Pharmaceuticals Inc

SXTC
Add to Watchlist
0.061USD
-0.012-16.42%
Close 07-31 16:00ETQuotes delayed by 15 min
58.54KMarket Cap
LossP/E TTM

More Details of China SXT Pharmaceuticals Inc Company

China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The Company sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The Company sells its products under the brand Suxuantang. The Company mainly operates its businesses in the domestic market.

China SXT Pharmaceuticals Inc Info

Ticker SymbolSXTC
Company nameChina SXT Pharmaceuticals Inc
IPO dateJan 04, 2019
CEOBeng (Lim Sze)
Number of employees75
Security typeOrdinary Share
Fiscal year-endJan 04
Address178 Taidong Road North
CityTAIZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code225300
Phone8652386298290
Websitehttps://www.sxtchina.com/
Ticker SymbolSXTC
IPO dateJan 04, 2019
CEOBeng (Lim Sze)

Company Executives of China SXT Pharmaceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
-100.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
-100.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of China SXT Pharmaceuticals Inc?

The top five shareholders of China SXT Pharmaceuticals Inc are: Mr. Feng Zhou

How many institutions hold shares of China SXT Pharmaceuticals Inc (SXTC)?

As of 2026Q1, 18 institutions hold shares of China SXT Pharmaceuticals Inc, with a combined market value of approximately 2.18K, accounting for 0.03% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 69.00.

What is the biggest source of revenue for China SXT Pharmaceuticals Inc?

In 2026Q1, the Regular TCMP business generated the highest revenue for China SXT Pharmaceuticals Inc, amounting to 1.44M and accounting for 82.86% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.